The announcement of a special meeting to seek approval for liquidation indicates that Fresh Tracks Therapeutics is considering dissolving the company and distributing its assets. This typically leads to a negative impact on the stock price as it suggests the company is not viable as a going concern. Investors may see this as a sign to exit their positions, leading to a potential decrease in stock price.